2016-06-21 | Reiterated Rating | Leerink Swann | Buy | |
2016-06-01 | Upgrade | Canaccord Genuity | Hold to Buy | $44.00 |
2016-05-26 | Reiterated Rating | Leerink Swann | Buy | |
2016-05-05 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-02-11 | Reiterated Rating | Jefferies | Hold | $24.00 to $25.00 |
2016-02-11 | Reiterated Rating | Cowen and Company | Buy | |
2016-02-11 | Reiterated Rating | Jefferies Group | Hold | $24.00 to $25.00 |
2016-02-11 | Lower Price Target | Barclays | Underweight | $27.00 to $25.00 |
2016-02-11 | Reiterated Rating | Piper Jaffray | In-Line | $32.00 to $31.00 |
2016-02-11 | Reiterated Rating | Canaccord Genuity | Buy | $38.00 |
2016-02-11 | Lower Price Target | Barclays PLC | Underweight | $27.00 to $25.00 |
2016-02-11 | Reiterated Rating | Piper Jaffray Cos. | In-Line | $32.00 to $31.00 |
2016-01-20 | Reiterated Rating | Leerink Swann | Outperform | $38.00 |
2016-01-11 | Downgrade | Piper Jaffray | Overweight to Neutral | $36.00 to $32.00 |
2016-01-08 | Reiterated Rating | Barclays | Sell | |
2016-01-07 | Boost Price Target | Cowen and Company | $40.00 | |
2016-01-07 | Boost Price Target | Barclays | Underweight | $25.00 to $27.00 |
2016-01-06 | Upgrade | Canaccord Genuity | Hold to Buy | $26.00 to $44.00 |
2015-11-19 | Upgrade | Cowen and Company | Market Perform to Outperform | $27.00 to $35.00 |
2015-11-16 | Reiterated Rating | Canaccord Genuity | Hold | $26.00 |
2015-11-04 | Upgrade | Raymond James | Market Perform to Outperform | $29.00 |
2015-11-04 | Upgrade | Raymond James Financial Inc. | Market Perform to Outperform | $29.00 |
2015-11-02 | Boost Price Target | JMP Securities | Outperform | $34.00 to $36.00 |
2015-11-02 | Lower Price Target | Canaccord Genuity | Hold | $30.00 to $28.00 |
2015-10-14 | Lower Price Target | Cowen and Company | Market Perform | $31.00 to $27.00 |
2015-09-02 | Initiated Coverage | Barclays | Underweight | $25.00 |
2015-08-28 | Upgrade | Raymond James | Underperform to Market Perform | |
2015-08-05 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 to $26.00 |
2015-05-28 | Reiterated Rating | Credit Suisse | Neutral | |
2015-05-28 | Reiterated Rating | Credit Suisse Group AG | Neutral | |
2015-05-06 | Lower Price Target | JMP Securities | Market Outperform | $36.00 to $33.00 |
2015-05-06 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 |
2015-02-11 | Reiterated Rating | William Blair | Outperform | |
2015-02-11 | Boost Price Target | JMP Securities | Market Outperform | $34.00 to $36.00 |
2015-02-11 | Set Price Target | Canaccord Genuity | Hold | $28.00 |
2014-12-19 | Initiated Coverage | Wells Fargo & Co. | Market Perform | |
2014-12-19 | Initiated Coverage | Wells Fargo | Market Perform | |
2014-11-07 | Reiterated Rating | Credit Suisse | Neutral | $28.00 to $32.00 |
2014-11-05 | Reiterated Rating | Canaccord Genuity | Hold | $27.00 to $30.00 |
2014-11-05 | Reiterated Rating | Bank of America | Buy | $28.00 to $30.00 |
2014-11-05 | Reiterated Rating | Bank of America Corp. | Buy | $28.00 to $30.00 |
2014-08-11 | Reiterated Rating | Canaccord Genuity | Hold | $30.00 to $27.00 |
2014-05-07 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $29.00 to $28.00 |
2014-02-07 | Downgrade | Credit Suisse | Outperform to Neutral | |
2014-02-05 | Downgrade | Bank of America | Underperform | $30.00 to $28.00 |
2014-02-05 | Lower Price Target | JMP Securities | Outperform | $38.00 to $34.00 |
2014-02-05 | Lower Price Target | Jefferies Group | $33.00 to $28.00 | |
2013-11-07 | Boost Price Target | BMO Capital Markets | Underperform | $18.00 to $20.00 |
2013-11-06 | Lower Price Target | Canaccord Genuity | Hold | $35.00 to $33.00 |
2013-11-06 | Upgrade | William Blair | Market Perform to Outperform | |
2013-10-01 | Downgrade | Bank of America | Neutral to Underperform | $36.00 to $33.00 |
2013-09-23 | Downgrade | Raymond James | Market Perform to Underperform | |
2013-08-02 | Reiterated | MLV & Co | Hold | $30 to $35 |
2012-02-21 | Downgrade | GARP Research | Buy to Neutral | |
2012-02-08 | Downgrade | MLV & Co | Buy to Hold | $31.50 to $30 |
2011-12-12 | Reiterated | Ladenburg Thalmann | Buy | $26 to $32 |
2011-11-02 | Upgrade | Ladenburg Thalmann | Neutral to Buy | $26 |
2011-10-11 | Reiterated | RBC Capital Mkts | Sector Perform | $27 to $21 |
2011-10-05 | Initiated | Oppenheimer | Perform | $20 |
2011-02-09 | Downgrade | Ladenburg Thalmann | Buy to Neutral | |
2010-04-21 | Initiated | RBC Capital Mkts | Sector Perform | |
2010-04-14 | Initiated | William Blair | Mkt Perform | |
2010-01-22 | Upgrade | Piper Jaffray | Neutral to Overweight | |
2010-01-21 | Initiated | Jefferies & Co | Hold | $18 |
2010-01-08 | Initiated | ThinkEquity | Buy | |
2009-06-11 | Upgrade | Thomas Weisel | Market Weight to Overweight | $23 |
2008-10-08 | Initiated | Oppenheimer | Perform | |
2008-09-08 | Downgrade | Canaccord Adams | Buy to Hold | $24 to $22 |
2008-05-07 | Reiterated | Canaccord Adams | Buy | $22 to $24 |
2016-06-21 | Reiterated Rating | Leerink Swann | Buy | |
2016-06-01 | Upgrade | Canaccord Genuity | Hold to Buy | $44.00 |
2016-05-26 | Reiterated Rating | Leerink Swann | Buy | |
2016-05-05 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-02-11 | Reiterated Rating | Jefferies | Hold | $24.00 to $25.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In GHDX 17 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1.60M |
BlackRock Fund Advisors | 1.02M |
BlackRock Institutional Trust Company, N.A. | 0.70M |
OPPENHEIMER FUNDS INC | 0.47M |
DECADE CAPITAL MANAGEMENT LLC | 0.42M |
BLACKROCK ADVISORS LLC | 0.38M |
TEACHERS ADVISORS INC | 0.26M |
Numeric Investors LLC | 0.21M |
TIAA CREF INVESTMENT MANAGEMENT LLC | 0.18M |
BlackRock Group LTD | 0.14M |
RUSSELL FRANK CO/ | 0.10M |
BlackRock Investment Management, LLC | 87943 |
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 27437 |
Independent Portfolio Consultants, Inc. | 15951 |
Airain ltd | 14489 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
BAKER BROS. ADVISORS LP | 1.08% (339585) | ACAD / AQXP / BCRX / GHDX / IDRA / INCY / MRTX / SGEN / XOMA / |
Shak Steven EVP of R&D & CMO | 1.07% (335916) | GHDX / |
BAKER FELIX | 1.01% (319993) | ACAD / BCRX / GEVA / GHDX / MRTX / SGEN / |
Popovits Kimberly J President and CEO | 0.75% (236157) | ABIO / GHDX / ZSPH / |
Cohen Fred E | 0.21% (67124) | BCRX / CDNA / FPRX / GHDX / ROKA / TNDM / VCYT / |
Cole G Bradley COO | 0.14% (44754) | GHDX / |
Radford Jason W. Chief Legal Officer | 0.12% (38820) | GHDX / |
Pla Frederic Chief Bus & Prod Dev Officer | 0.12% (38712) | GHDX / |
McEachron Kim Chief People Officer | 0.11% (33727) | GHDX / |
Vaughn James J Chief Commercial Officer | 0.09% (29655) | GHDX / |
Schorno Dean L CFO | 0.08% (24524) | GHDX / |
Febbo Phillip G. Chief Medical Officer | 0.07% (21387) | GHDX / |
Leber Laura Chief Communication Officer | 0.05% (16531) | GHDX / |
HIBBS KATHY L SVP & General Counsel | 0.05% (15787) | GHDX / |
GRAHAM GINGER L | 0.03% (10058) | CLVS / GHDX / WAG / |
LIVINGSTON RANDALL S | 0.02% (6149) | EHTH / GHDX / PACB / |
FUCHS HENRY J | 0.02% (5837) | BMRN / GHDX / MRTX / |
COLELLA SAMUEL D | 0.02% (5305) | ALXA / FLDM / FLXN / GHDX / VCYT / |
MYERS WOODROW A JR | 0.01% (3880) | ESRX / GHDX / KOOL / LPDX / |